2377. Outcomes in Patients With History of Cardiac or Vascular Disease (CV) During Treatment of Acute Bacterial Skin And Skin Structure Infection (ABSSSI) With Delafloxacin (DLX) v...

por Oguchi, Godson, Beasley, Richard, Lawrence, Laura, Tseng, Carol, Cammarata, Sue K
Publicado 2018

2378. Resolution of Signs and Symptoms (S&S) of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) With Delafloxacin (DLX) IV/Oral Therapy

por Pullman, John, O’Riordan, William, Lawrence, Laura, Quintas, Megan, Tseng, Carol, Cammarata, Sue K
Publicado 2018

470. Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in Patients with Significant Drug Abuse: Outcomes from Global Phase 3 Studies of Delafloxacin (DLX)

por Overcash, J Scott, O’Riordan, William, Quintas, Megan, Lawrence, Laura, Tseng, Carol, Cammarata, Sue
Publicado 2019